尼克-4已成为乳腺癌的有吸引力的目标
Hui Wang1, Dejuan Sun1, Jinxia Chen1
1Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.
乳腺癌中,包括三阴性乳腺癌 (TNBC) 中,Nectin-4的过度表达. 用单克隆抗体等疗法向Nectin-4显示出治疗这种常见的女性恶性瘤的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 全球乳腺癌发病率正在上升,这对健康构成重大挑战.
- 三阴性乳腺癌 (TNBC) 仍然是一个具有有限有效治疗选择的亚型.
- 细胞粘附蛋白Nectin-4越来越多地被认为是它在各种癌症中的作用.
研究的目的:
- 系统地审查Nectin-4在乳腺癌中的重要性.
- 为了阐明Nectin-4在乳腺癌中的作用背后的分子机制.
- 为突出乳腺癌的Nectin-4特定治疗策略.
主要方法:
- 关于Nectin-4和乳腺癌的研究的系统文献综述.
- 对涉及癌症进展中的Nectin-4分子机制的分析.
- 目前和拟议的Nectin-4向疗法的汇编.
主要成果:
- 在乳腺癌组织中,nectin-4被过度表达.
- 尼克-4在细胞粘附和癌症发育中起作用.
- 用抗体和抑制剂向Nectin-4已经显示出积极的治疗结果.
结论:
- 尼克-4是乳腺癌发病的一个重要因素.
- 尼克-4是乳腺癌,特别是TNBC的有前途的治疗标.
- 进一步开发Nectin-4向疗法可以改善患者的治疗结果.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:09Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Drugs that Stabilize Microtubules
Non-Canonical Wnt Signaling Pathways
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
